Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in hormone refractory prostate cancer
NCT00216099Phase 2Completed
- Start
- Feb 2005
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in prostate cancer (PCa). Started Feb 2005; status: completed.
02
Drugs
pemetrexed
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00216099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216099.